Grufity logoGrufity logo
Stocks
Funds
Screener
Sectors
Watchlists
APDN

APDN - Applied DNA Sciences Inc Stock Price, Fair Value and News

$1.51-0.02 (-1.31%)
Market Closed

22/100

APDN

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

22/100

APDN

STOCK SCORE

High Scoring Large Cap stocks have outperformed low scoring stocks by 90% over last 10 years

Price Targets

Target 1Y

$1.34

Target 3M

$1.53

Target 6M

$1.42

APDN Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

APDN Price Action

Last 7 days

-4.8%

Last 30 days

-31.5%

Last 90 days

-57.9%

Trailing 12 Months

-98.9%

APDN RSI Chart

APDN Stock Valuation Analysis

Valuation

Login to View

Max Portfolio %

Login to View

APDN Valuation

Market Cap

6.6M

Price/Earnings (Trailing)

-0.43

Price/Sales (Trailing)

2.46

EV/EBITDA

-0.33

Price/Free Cashflow

-0.53

APDN Price/Sales (Trailing)

The Good, Bad and Ugly

Growth

Profitability

Size

Dilution Risk

Balance Sheet

Momentum

Funds Popularity

Insider Trading

Price Targets

Target 1Y

$1.34

Target 3M

$1.53

Target 6M

$1.42

APDN Fundamentals

APDN Revenue

Revenue (TTM)

2.7M

Rev. Growth (Yr)

-59.1%

Rev. Growth (Qtr)

-34.48%

APDN Earnings

Earnings (TTM)

-15.2M

Earnings Growth (Yr)

-60.16%

Earnings Growth (Qtr)

-32.84%

APDN Profitability

Operating Margin

42.44%

EBT Margin

-584.02%

Return on Equity

-659.13%

Return on Assets

-342.34%

Free Cashflow Yield

-190.47%

APDN Investor Care

Shares Dilution (1Y)

6161.01%

Diluted EPS (TTM)

-347.98

Historical Charts for Stock Metrics

Get all data in R, Python etc through our Historical Stock Data APIs
Net sales
YearQ1Q2Q3Q4
20253.1M3.0M2.7M0
20245.5M3.1M2.8M3.1M
202317.5M16.1M13.4M9.0M
202215.1M17.6M18.2M19.3M
20215.0M6.3M9.0M11.6M
20204.9M3.3M1.9M2.9M
20193.9M4.9M5.4M5.1M
20184.6M3.9M3.9M4.1M
20174.1M5.2M4.8M4.5M
20168.1M6.5M4.2M3.8M
20154.2M5.7M9.0M9.1M
20142.6M2.8M2.7M3.4M
20131.5M1.6M2.0M2.3M
20121.5M1.8M1.9M1.7M
2011744.3K856.6K968.8K1.2M
2010000632.1K
Get all data in R, Python etc through our Historical Stock Data APIs

About Applied DNA Sciences Inc

APDN
Applied DNA Sciences, Inc., a biotechnology company, develops and commercializes technologies to produce and detect deoxyribonucleic acid (DNA) in the Americas, Europe, Asia, and internationally. The company operates through three segments: Therapeutic DNA Production Services; MDx Testing Services; and DNA Tagging and Security Products and Services. The Therapeutic DNA Production Services segment develops and commercializes the LinearDNA platform, which enables a cell-free manufacture of high-fidelity synthetic DNA sequences for use in nucleic acid-based therapeutics. The MDx Testing Services segment provides clinical molecular diagnostics (MDx) testing and clinical laboratory testing services; COVID-19 testing services, including test scheduling, sample collection, and automated results reporting for higher education institutions, private clients, and businesses under the safeCircle trademark; polymerase chain reaction (PCR)-based MDx testing services for the Monkeypox virus; and MDx test kits and related supplies, as well as validates pharmacogenetics (PGx) testing services. The DNA Tagging and Security Products and Services segment offers SigNature Molecular Tags, which provides a methodology to authenticate goods within large and complex supply chains for materials, such as cotton, leather, pharmaceuticals, nutraceuticals, and other products; SigNify IF portable DNA readers and SigNify consumable reagent test kits, which offers a front-line solution for supply chain integrity backed with forensic-level molecular tag authentication; and fiberTyping, which uses PCR-based DNA detection to detect a product's naturally occurring DNA sequences for the purposes of product provenance authentication and supply chain security. The company was formerly known as Datalink Systems, Inc. and changed its name to Applied DNA Sciences, Inc. in 2002. Applied DNA Sciences, Inc. was founded in 1983 and is headquartered in Stony Brook, New York.
 CEO
 WEBSITEadnas.com
 SECTORHealthcare
 INDUSTRYDiagnostics & Research
 EMPLOYEES61

Applied DNA Sciences Inc Frequently Asked Questions

APDN is the stock ticker symbol of Applied DNA Sciences Inc. Every public company that trades on a stock exchange gets a ticker symbol.

As of Tue Jan 27 2026, market cap of Applied DNA Sciences Inc is 6.59 Million. The market capitalization is calculated by multiplying the stock price with the number of shares outstanding.

You can check APDN's fair value in chart for subscribers.

The fair value guage provides a quick view whether APDN is over valued or under valued. Whether Applied DNA Sciences Inc is cheap or expensive depends on the assumptions which impact Applied DNA Sciences Inc's fair value. We provide several scenarios of inflation and growth to encompass these range of assumptions for APDN.

As of Tue Jan 27 2026, APDN's PE ratio (Price to Earnings) is -0.43 and Price to Sales (PS) ratio is 2.46. The price to earnings and price to sales ratio are two most important valuation metrics for any company. PE ratio tell us the number of years of earnings investors are ready to pay for owning the company. Historically, S&P500 price to earnings ratio has fallen below 12 during periods of gloom and gone past 30 during periods of euphoria. APDN PE ratio will change depending on the future growth rate expectations of investors.

In the past 10 years, Applied DNA Sciences Inc has provided -0.753 (multiply by 100 for percentage) rate of return.